SENOTHERAPEUTICS, AGING, AND AGE-RELATED DISEASES

Abstract

Increased translational clinical trials are addressing the utility of senotherapeutic agents as interventions for aging in general and for age-related diseases. Numerous pre-clinical trials have provided a good rationale for human clinical trials which are being increasingly proposed.